Céline Gagnon

Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists

Céline Gagnon, Paul J. Bédard, Thérèse Di Paolo · European Journal of Pharmacology · 1990 · 87 citations

Psychoactive Drug, Addiction, Medicine +10

Effect of adding the D1 agonist CY 208–243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors

Baltazar Gomez‐Mancilla, R. Boucher, Céline Gagnon et al. · Movement Disorders · 1993 · 45 citations

Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys.

Bédard Pj, Baltazar Gomez‐Mancilla, Pierre Blanchette et al. · PubMed · 1993 · 45 citations

D2 Agonists, Medicine, Selective D1 +8

Levodopa-induced dyskinesia: facts and fancy. What does the MPTP monkey model tell us?

P.J. Bédard, Baltazar Gomez Mancilla, Pierre Blanchette et al. · PubMed · 1992 · 45 citations

Neurological Disorder, Neurotransmitter, Dopamine Receptors +18

Levodopa-Induced Dyskinesia: Facts and Fancy. What Does the MPTP Monkey Model Tell Us?

Paul J. Bédard, Baltazar Gomez Mancilla, Pierre Blanchette et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 1992 · 37 citations · Full text

Neurological Disorder, Neurotransmitter, Dopamine Receptors +17